title: [Individualization of the antihelicobacter therapy at functional dyspepsia in children and adolescents].
abstract: We have discussed the individual anthyhelicobacter treatment duration from 7 to 14 days for functional dyspeptic syndrome in children and adolescent. We have performed 3-year follow-up results in different patients group: H. pylori reinfection, H. pylori as an advanced and patient with successfully H. pylori eradication. There is no difference between all groups during 3 years follow-up accordingly clinical, endoscopes and histological dates. However we have proved a necessity for a long-time therapy (to 10-14 days) for patients who have a functional dyspepsia and previous treated with antacids and antisecretic drug, patients with hypertrophic antral gastropathy picture of EGDS, family ulcer disease and erosive gastric disease before. In other cases the 7-days-cours of eradication therapy should be recommended or the specific therapy may be delayed.
authors.forename: A A
authors.initials: AA
authors.lastname: Zviagin
authors.forename: P L
authors.initials: PL
authors.lastname: Shcherbakov
authors.forename: A V
authors.initials: AV
authors.lastname: Pochivalov
authors.forename: V V
authors.initials: VV
authors.lastname: Kashnikov
mesh_terms: D000293:Adolescent; D000863:Antacids / Q000008:administration & dosage*; D002648:Child; D004415:Dyspepsia / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D013997:Time Factors
chemical_list: D000863:Antacids